GSK Expands Collaboration to Deploy Cellular Model MORGAN in $110M Deal
chaitjo · x · 2026-08-01
Biotech company Relation Therapeutics announced an expanded collaboration with pharmaceutical giant GSK to deploy MORGAN, its flagship cellular foundation model. The deal will bring up to $110 million in upfront and success-based milestone payments, signaling strong industry validation for AI-driven drug discovery.
Related event: Relation and GSK Expand AI Drug Discovery Partnership to $110M(2 posts)→
More from Venture
- Anthropic IPO math: Amazon+Google set for ~$600B, FTX sold its stake 100x too early — simonada · 2026-10-16
- China's AI boom drives up to 660% profit surges for domestic chip firms; GPU maker MetaX turns profitable — pstAsiatech · 2026-10-16
- Dev adds Google Merchant Center to his MCP server — and explains how it beats Google's official one — DutchSEOnerd · 2026-10-16
- The 'sci-fi make it till you make it' playbook: Musk pioneered it, Altman copied it — Linahuaa · 2026-10-16
- A $50 site of 50,000 fake stats got cited by ChatGPT for 7 months — metehan777 · 2026-10-16
- Maker Who Paid $37K/Month to Affiliates Shares 5 Ways to Earn Your First $1,000 in 2026 — tibo_maker · 2026-10-16